Category:
![](https://efcca.org/sites/default/files/styles/large/public/Journal%20of%20Crohn%27s%20and%20Colitis_1920x1080.png?itok=dLLiCzZg)
Paediatric inflammatory bowel disease: a multi-stakeholder perspective to improve development of drugs for children and adolescents
September, 2022
The study aims to find potential advanced treatment options for children with inflammatory bowel disease. A 2-day virtual meeting was held on April 14–15, 2021, for multi-stakeholders (clinical academics, patient community, pharmaceutical companies, and regulators) to discuss their perspectives on paediatric drug development for inflammatory bowel disease.